Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sarah A Holstein

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 25

Top Venues

Clinical and translational medicine

International journal of molecular sciences

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Leukemia

Roswell Park Cancer Institute

University of Iowa Roy J and Lucille A Carver College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roswell Park Cancer Institute

United States

Associate Professor :: Medicine

Education History

University of Iowa Roy J and Lucille A Carver College of Medicine

United States

PHD

Publications

Andrew C Pham, Sarah A Holstein, Gloria E O Borgstahl
Structural insight into geranylgeranyl diphosphate synthase (GGDPS) for cancer therapy. Molecular cancer therapeutics (2023)
Molly E Muehlebach, Sarah A Holstein
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. Clinical and translational medicine 13 (1) (2023)
Molly E Muehlebach, Sarah A Holstein
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. Clinical and translational medicine 13 (1) (2023)
Molly E Muehlebach, Sarah A Holstein
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. Clinical and translational medicine 13 (1) (2023)
Sarah A Holstein, Shakira J Grant, Tanya M Wildes
Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapy in Multiple Myeloma: Moving Into the Future. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Staci L Haney, Dan Feng, Sai Sundeep Kollala, Yashpal S Chhonker, Michelle L Varney, Jacob T Williams, James B Ford, Daryl J Murry, Sarah A Holstein
Investigation of the activity of a novel tropolone in osteosarcoma. Drug development research (2023)
Molly E Muehlebach, Sarah A Holstein
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. Clinical and translational medicine 13 (1) (2023)
Molly E Muehlebach, Sarah A Holstein
Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. Clinical and translational medicine 13 (1) (2023)
Staci L Haney, Michelle L Varney, Jacob T Williams, Lynette M Smith, Geoffrey Talmon, Sarah A Holstein
Geranylgeranyl diphosphate synthase inhibitor and proteasome inhibitor combination therapy in multiple myeloma. Experimental hematology & oncology 11 (1) (2022)
Staci L Haney, Sarah A Holstein
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma. International journal of molecular sciences 24 (1) (2022)
Staci L Haney, Sarah A Holstein
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma. International journal of molecular sciences 24 (1) (2022)
Staci L Haney, Dan Feng, Yashpal S Chhonker, Michelle L Varney, Jacob T Williams, Lynette M Smith, James B Ford, Daryl J Murry, Sarah A Holstein
Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma. Drug development research (2022)
Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej J Jakubowiak, Yvonne Efebera, Brandi N Reeves, Tanya Wildes, Sarah A Holstein, Larry D Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, J Blake Bartlett, Jessica Vermeulen, Thomas S Lin, Paul Gerard Richardson, Peter Voorhees
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN. Blood cancer journal 12 (4) (2022)
Staci L Haney, Sarah A Holstein
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma. International journal of molecular sciences 24 (1) (2022)
Staci L Haney, Sarah A Holstein
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma. International journal of molecular sciences 24 (1) (2022)
Meghana Kesireddy, Sarah A Holstein
The era of lenalidomide maintenance therapy in multiple myeloma: settings for achieving best outcomes. Expert review of clinical pharmacology 15 (1) (2022)
Sarah A Holstein, Vera J Suman, Jens Hillengass, Philip L McCarthy
Future Directions in Maintenance Therapy in Multiple Myeloma. Journal of clinical medicine 10 (11) (2021)
Sarah A Holstein, Philip L McCarthy, Philip L McCarthy
Melflufen: A Next-Generation Nitrogen Mustard. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)
Radowan A Elnair, Sarah A Holstein
Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma. Drugs 81 (7) (2021)
Luciano José Megale Costa, Benjamin A Derman, Susan Bal, Surbhi Sidana, Saurabh Chhabra, Rebecca Silbermann, Jing C Ye, Curly T C M Morris, Robert F Cornell, Sarah A Holstein, Qian Shi, James Omel, Natalie S Callander, Wee Joo Chng, Vania Hungria, Ângelo Maiolino, Edward Stadtmauer, Sergio A Giralt, Marcelo Pasquini, Andrzej J Jakubowiak, Gareth J Morgan, Amrita Krishnan, Graham H Jackson, Mohamad Mohty, Maria-Victoria Mateos-Manteca, Meletious A Dimopoulos, Thierry Facon, Andrew Spencer, Jesus San Miguel, Parameswaran Hari, Saad Z Usmani, Salomon Manier, Phillip McCarthy, Shaji K Kumar, Francesca Gay, Juan José Lahuerta
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials. Leukemia 35 (1) (2020)
Staci L Haney, Yashpal S Chhonker, Michelle L Varney, Geoffrey Talmon, Lynette M Smith, Daryl J Murry, Sarah A Holstein
In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution. The Journal of pharmacology and experimental therapeutics 371 (2) (2019)
Staci L Haney, Michelle L Varney, Yashpal S Chhonker, Simon Shin, Kamiya Mehla, Ayrianne J Crawford, Heather Jensen Smith, Lynette M Smith, Daryl J Murry, Michael A Hollingsworth, Sarah A Holstein
Inhibition of geranylgeranyl diphosphate synthase is a novel therapeutic strategy for pancreatic ductal adenocarcinoma. Oncogene 38 (26) (2019)
Julia C Walk, Bruce P Ayati, Sarah A Holstein
Modeling the Effects of Multiple Myeloma on Kidney Function. Scientific reports 9 (1) (2019)
Sarah A Holstein, Vera J Suman, Philip L McCarthy
Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale. Leukemia 33 (2) (2019)
Yashpal S Chhonker, Staci L Haney, Veenu Bala, Sarah A Holstein, Daryl J Murry
Simultaneous Quantitation of Isoprenoid Pyrophosphates in Plasma and Cancer Cells Using LC-MS/MS. Molecules (Basel, Switzerland) 23 (12) (2018)

Sarah A Holstein.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sarah A Holstein